John Longshore

4.6k total citations · 1 hit paper
25 papers, 1.5k citations indexed

About

John Longshore is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Longshore has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Longshore's work include Genetics and Neurodevelopmental Disorders (9 papers), Cancer Genomics and Diagnostics (5 papers) and Genomic variations and chromosomal abnormalities (3 papers). John Longshore is often cited by papers focused on Genetics and Neurodevelopmental Disorders (9 papers), Cancer Genomics and Diagnostics (5 papers) and Genomic variations and chromosomal abnormalities (3 papers). John Longshore collaborates with scholars based in United States, France and Italy. John Longshore's co-authors include Reinhard Büttner, Fernando López‐Ríos, Etienne Rouleau, Nicola Normanno, Frédérique Penault‐Llorca, Sabine Merkelbach‐Bruse, James Amos‐Landgraf, Huntington F. Willard, Charles E. Schwartz and Robert M. Plenge and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

John Longshore

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Implementing TMB measurement in clinical practice: considerations on assay requirements

2019 247 citations Reinhard Büttner, John Longshore et al. ESMO Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Longshore United States	14	609	510	478	306	240	25	1.5k
Roberto Mendoza‐Londono Canada	26	1.2k 1.9×	1.0k 2.0×	151 0.3×	166 0.5×	136 0.6×	85	2.1k
Michael J. Friez United States	25	1.6k 2.7×	1.7k 3.3×	124 0.3×	95 0.3×	292 1.2×	82	3.1k
Michael M. Weil United States	26	652 1.1×	1.7k 3.3×	309 0.6×	512 1.7×	399 1.7×	86	2.8k
Jay W. Ellison United States	23	1.2k 2.1×	1.2k 2.4×	144 0.3×	249 0.8×	233 1.0×	52	2.6k
Brian A. Gray United States	20	567 0.9×	517 1.0×	143 0.3×	103 0.3×	102 0.4×	38	1.1k
Rosa Miró Spain	26	629 1.0×	871 1.7×	416 0.9×	196 0.6×	608 2.5×	113	2.2k
Eric M. Thompson United States	24	373 0.6×	1.1k 2.3×	112 0.2×	122 0.4×	105 0.4×	77	2.0k
Predrag Slijepčević United Kingdom	27	338 0.6×	1.7k 3.4×	231 0.5×	99 0.3×	341 1.4×	89	2.6k
Eamonn Sheridan United Kingdom	28	776 1.3×	1.2k 2.4×	289 0.6×	263 0.9×	313 1.3×	74	2.7k
Tohru Tsukui Japan	18	711 1.2×	2.2k 4.3×	213 0.4×	85 0.3×	106 0.4×	28	2.6k

Countries citing papers authored by John Longshore

Since Specialization

Citations

This map shows the geographic impact of John Longshore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Longshore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Longshore more than expected).

Fields of papers citing papers by John Longshore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Longshore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Longshore. The network helps show where John Longshore may publish in the future.

Co-authorship network of co-authors of John Longshore

This figure shows the co-authorship network connecting the top 25 collaborators of John Longshore. A scholar is included among the top collaborators of John Longshore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Longshore. John Longshore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alborelli, Ilaria, Melanie Demes, Peter J. Wild, et al.. (2025). ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay. SHILAP Revista de lepidopterología. 6(3). 19–19.

Horgan, Denis, Tanja Čufer, Francesco Gatto, et al.. (2022). Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring. Healthcare. 10(9). 1714–1714. 21 indexed citations

Büttner, Reinhard, John Longshore, Fernando López‐Ríos, et al.. (2019). Implementing TMB measurement in clinical practice: considerations on assay requirements. ESMO Open. 4(1). e000442–e000442. 247 indexed citations breakdown →

Longshore, John, et al.. (2018). Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test. Journal of Thrombosis and Thrombolysis. 47(1). 87–95.

Büttner, Reinhard, John R. Gosney, Birgit Guldhammer Skov, et al.. (2017). Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 35(34). 3867–3876. 297 indexed citations

Levy, Benjamin, Marc Chioda, John Longshore, et al.. (2015). Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations. The Oncologist. 20(10). 1175–1181. 25 indexed citations

Fisher, Kevin E., C. M. S. Cohen, Momin T. Siddiqui, et al.. (2014). Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Human Pathology. 45(11). 2281–2293. 39 indexed citations

Amos‐Landgraf, James, et al.. (2006). X Chromosome–Inactivation Patterns of 1,005 Phenotypically Unaffected Females. The American Journal of Human Genetics. 79(3). 493–499. 229 indexed citations

Nolin, Sarah L., W. Ted Brown, Anne Glicksman, et al.. (2003). Expansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles. The American Journal of Human Genetics. 72(2). 454–464. 276 indexed citations

10.

Bagwell, Christopher E., et al.. (2002). Molecular diversity of diazotrophs in oligotrophic tropical seagrass bed communities. FEMS Microbiology Ecology. 39(2). 113–119. 67 indexed citations

11.

Longshore, John, et al.. (2001). Ciliary Dyskinesia Associated With Hydrocephalus and Mental Retardation in a Jordanian Family. Mayo Clinic Proceedings. 76(12). 1219–1224. 46 indexed citations

12.

Shaffer, Lisa G., et al.. (2001). American College of Medical Genetics Statement on Diagnostic Testing for Uniparental Disomy. Genetics in Medicine. 3(3). 206–211. 80 indexed citations

13.

Rousseau, Frédéric, Helle Hjalgrim, Elke Holinski‐Feder, et al.. (2000). FMR1 CGG expansion to full mutation: What is the lower limit in premutation females?. The American Journal of Human Genetics. 67(4). 365–365. 2 indexed citations

14.

Michaelis, Ron C., Khalid Sossey‐Alaoui, Cindy Skinner, et al.. (2000). The HOPA Gene Dodecamer Duplication Is Not a Significant Etiological Factor in Autism. Journal of Autism and Developmental Disorders. 30(4). 355–358. 9 indexed citations

15.

Friez, Michael J., Amanda Krause, Lucia Castiglia, et al.. (2000). Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated with mental retardation. Human Genetics. 106(1). 36–39. 11 indexed citations

16.

Tassone, Flora, et al.. (1999). Tissue‐specific methylation differences in a fragile X premutation carrier. Clinical Genetics. 55(5). 346–352. 16 indexed citations

17.

Tarleton, Jack, et al.. (1997). Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles. American Journal of Medical Genetics. 73(4). 447–455. 13 indexed citations

18.

Han, Jian, Judith Knops, John Longshore, & Peter H. King. (1996). Localization ofHuman elav-like Neuronal Protein 1(Hel-N1) on Chromosome 9p21 by Chromosome Microdissection Polymerase Chain Reaction and Fluorescencein SituHybridization. Genomics. 36(1). 189–191. 6 indexed citations

19.

Descartes, Maria, Kim M. Keppler‐Noreuil, Judith Knops, et al.. (1996). Terminal deletion of the long arm of chromosome 4 in a mother and two sons. Clinical Genetics. 50(6). 538–540. 26 indexed citations

20.

Han, Jian, et al.. (1994). Over-representation of the disease associated (CAG) and (CGG) repeats in the human genome. Nucleic Acids Research. 22(9). 1735–1740. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact